Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,764 public trials 2,078 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC

NCT06855212

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

NCT04759911

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +25 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

University of Michigan Health Systems Ann Arbor, Michigan, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC

NCT05546879

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: CHU de GRENOBLE ALPES Grenoble, Alpes, France

CHU Angers Angers, France

Hôpital Haut Lêveque Bordeaux, France

12 Hôpital St Joseph Marseille, France

View Trial Details

Active, Not Recruiting

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

NCT04388852

Conditions: Adenocarcinoma, Aggressive Variant Prostate Carcinoma, Carcinoma, +34 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

3D Specimen Maps for RT Planning

NCT05743569

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +8 more
Locations: Vanderbilt Medical Center Nashville, Tennessee, United States

View Trial Details

Active, Not Recruiting

Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)

NCT02984566

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Nepean Hospital Penrith, New South Wales, Australia

Westmead Hospital Westmead, New South Wales, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Active, Not Recruiting

Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma

NCT06035224

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Shanghai Renji Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT06378177

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Anhui Cancer Hospital Hefei, Anhui, China

Beijing Cancer Hospital Beijing, Beijing Municipality, China

Beijing Tongren Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China

Fujian cancer hospital Fuzhou, Fujian, China

View all 16 locations

View Trial Details

Active, Not Recruiting

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

NCT05239728

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Mayo Clinic in Arizona - Phoenix ( Site 3554) Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center ( Site 3567) Duarte, California, United States

Moores Cancer Center-Clinical Trials Office- Genitourinary ( Site 3516) La Jolla, California, United States

UCLA Hematology/Oncology - Westwood (Building 200 Suite 140)-Department of Urology/Institute of Uro ( Site 3520) Los Angeles, California, United States

View all 285 locations

View Trial Details

Active, Not Recruiting

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

NCT05574101

Conditions: Carcinoma, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, +14 more
Locations: University of Colorado (Data Collection Only) Aurora, Colorado, United States

Moffitt Cancer Center (Data Collection Only) Tampa, Florida, United States

Memorial Sloan Kettering Cancer Center at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States

View all 13 locations

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions